Senthil Sundaram is the founder of Terns Pharmaceuticals. Terns Pharmaceuticals has raised $197M in total funding. Latest round: IPO.
Senthil Sundaram is the CEO and founder of Terns Pharmaceuticals, Inc., a biotechnology company established in 2017. Based in Foster City, CA, US, Terns Pharmaceuticals focuses on developing treatments for patients with chronic liver diseases. The company has raised a total of $197 million over three funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library